The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer

Surgery

Volumn 144, Issue 5, 2008, Pages 721-724

  Pitt, Susan C ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CHROMOGRANIN A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RET;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL SURVIVAL; GENE MUTATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; THYROID MEDULLARY CARCINOMA; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA, MEDULLARY; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RET; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 54549114194     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.06.028     Document Type: Review

References (10)

1. Drosten M., Hilken G., Böckmann M., Rödicker F., Mise N., Cranston A.N., et al. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid cancer. J NCI 96 (2004) 1231-1239
2. Liu Z., Falola J., Zhu X., Gu Y., Kim L.T., Sarosi G.A., et al. Antiproliferative effects of Src inhibition on medullary thyroid cancer. J Clin Endocrinology 89 (2004) 3503-3509
3. Kunnimalaiyaan M., Ndiaye M., and Chen H. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Surgery 140 (2006) 1009-1015
4. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., and Chen H. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery 134 (2003) 866-871
5. Vaccaro A., Chen H., and Kunimalaiyaan M. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer. Anticancer Drugs 17 (2006) 849-853
6. Kunnimalaiyaan M., Vaccaro A.M., Ndiaye M.A., and Chen H. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem 281 (2006) 39819-39830
7. Kunnimalaiyaan M., Vaccaro A.M., Ndiaye M.A., and Chen H. Inactivation of glycogen synthase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 6 (2007) 1151-1158
8. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
9. Segouffin-Cariou C., and Billaud M. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 275 (2000) 3568-3576
10. Salvatore D., Melillo R.M., Monaco C., Visconti R., Gianfranco F., Vecchio G., et al. Increased in vivo phosphorylation of Ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. Cancer Res 16 (2001) 1426-1431